Xinyue Hang, Jin Yang. "Pyrotinib versus pertuzumab plus trastuzumab and taxane as first-line therapy for HER2-positive advanced breast cancer: A retrospective cohort study using propensity score overlap weighting.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e13024